CircKIAA0907 Retards Cell Growth, Cell Cycle, and Autophagy of Gastric Cancer In Vitro and Inhibits Tumorigenesis In Vivo via the miR-452-5p/KAT6B Axis.

CONCLUSIONS This work demonstrated that circKIAA0907 has diagnostic and therapeutic value in GC by acting as an oncogenic molecule via the miR-452-5p/KAT6B axis. PMID: 32722658 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32722658?dopt=Abstract

Source: Medical Science Monitor - July 30, 2020 Category: Research Tags: Med Sci Monit Source Type: research